Cargando...
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
The efficacy, safety, and tolerability of Lu AA21004 vs. placebo using venlafaxine XR as active reference in patients with DSM-IV-TR major depressive disorder (MDD) were evaluated. Lu AA21004 is a novel antidepressant that is a 5-HT(3) and 5-HT(7) receptor antagonist, 5-HT(1A) receptor agonist, 5-HT...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Cambridge University Press
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3349292/ https://ncbi.nlm.nih.gov/pubmed/21767441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1461145711001027 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|